Source: European Medicines Agency (EU) Revision Year: 2012 Publisher: GE Healthcare AS, Nycoveien 1-2, P.O. Box 4220 Nydalen, NO-0401, OSLO, Norway
TESLASCAN 0.01 mmol/ml solution for infusion.
Pharmaceutical Form |
---|
Solution for infusion. A clear bright to dark yellow solution. TESLASCAN has the following physicochemical properties: pH: 7.0-8.0. |
Each ml contains 7.57 mg of anhydrous mangafodipir trisodium, 0.01 mmol (10 μmol), equivalent to 6.91 mg of mangafodipir. 50 ml contains 378.5 mg of anhydrous mangafodipir trisodium, 0.50 mmol (500 μmol), equivalent to 345.5 mg of mangafodipir.
Excipient: Sodium 0.16 mmol (3.6 mg)/ml equivalent to 126 mg per normal dose of 35 ml.
For a full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Mangafodipir |
Mangafodipir is a chelate containing the metal manganese – which has paramagnetic properties and is responsible for the contrast enhancement effect in MRI – and the ligand fodipir (dipyridoxyl diphosphate). Manganese is preferentially taken up by normal liver parenchyma and also in the pancreas so that contrast enhancement between abnormal and normal tissue can be expected. |
List of Excipients |
---|
Ascorbic acid |
50 ml clear, colourless vials (type 1 glass). The containers are closed with rubber stoppers and sealed with aluminium caps with polypropylene lids.
TESLASCAN is supplied in packs of 1 × 50 ml and 10 × 50 ml vials.
Not all pack sizes may be marketed.
GE Healthcare AS, Nycoveien 1-2, P.O. Box 4220 Nydalen, NO-0401, OSLO, Norway
EU/1/97/040/001
EU/1/97/040/002
Date of first authorisation: 22.05.1997
Date of latest renewal: 22.05.2007
Drug | Countries | |
---|---|---|
TESLASCAN | Turkey |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.